• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , Feb. 24

PFIZER Ltd has posted a 125 per cent growth in net profit at Rs 13.7 crore for three months ended November 30, 2004, compared with Rs 6.1 crore for the fourth quarter ended November 30, 2003.

A senior executive with Pfizer attributed this growth to improved operating margins and cost efficiencies.

Total income has increased from Rs 143.7 crore in the fourth quarter last year to Rs 149.3 crore for the quarter ended November 30, 2004. The fourth quarter results reflect the performance of only Pfizer Ltd, the company told BSE. Meanwhile, the company posted a net profit of Rs 45.5 crore for the year ended November 30, 2004 (Rs 27.51 crore). Total income for the year under review stands at Rs 597 crore for the year ended November 30, 2004 (Rs 515.1 crore). Recently, the Bombay High Court had cleared the scheme of amalgamation of erstwhile Pharmacia Healthcare Ltd with Pfizer Ltd. In view of this approval, effective December 1, 2003, the audited figures for the year ended November 30, 2004, includes the figures of Pharmacia Healthcare Ltd, the company said. As a result, the audited figures for the year ended November 30, 2004, are not comparable with the figures for the previous periods.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Improved margins push up Pfizer net in Q4

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line